Search

everythinglearnresearchcommunity

for

Search:↓

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Moxibustion may help improve ovarian function by changing androgen levels.

Effective management of hyperandrogenism in young women requires accurate diagnosis and tailored treatment.

Finasteride can cause lasting skin lightening in women.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

More men have Androgenic Alopecia than women, it's often inherited, and stress can contribute to it.

Removing one ovary helped treat a woman's severe PCOS symptoms when medicine didn't work.

More men have androgenic alopecia than women, with stress linked to the condition in both genders.

The conclusion is that more women in their forties are getting AGA and stress is linked to AGA in both men and women.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

The document discusses a young boy with autism and early puberty but does not provide a conclusion on managing his behavior.

Physical activity significantly improved symptoms of PCOS in a patient.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

Cinnamon may help manage obesity and improve conditions related to Polycystic Ovary Syndrome (PCOS).

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

PCOS phenotypes A and B are more common and linked to higher health risks in women from the Ecuadorian Andes.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.